If anybody is interested, let me know. We'll organize when and where.
We have members of the Department of Health here today. There are no opening statements, just questions.
We have Catherine Parker, director general of the biologics and genetic therapies directorate, health products and food branch; Karen Reynolds, executive director of the office of pharmaceuticals management strategies; and Dr. John Patrick Stewart, director general of the therapeutic products directorate.
We're going to start our questions with Mr. McKinnon.